HAP1B Inhibitors
HAP1B inhibitors are a class of chemical compounds designed to target and modulate the function of huntingtin-associated protein 1B (HAP1B). HAP1B, a protein implicated in intracellular trafficking and vesicular transport, is primarily expressed in the brain and plays a crucial role in neuronal function. HAP1B is known for its involvement in microtubule-based transport processes, where it associates with motor proteins like kinesin and dynein, facilitating the movement of vesicles, organelles, and proteins within neurons. Inhibitors of HAP1B are designed to interfere with these processes, affecting the normal intracellular dynamics where HAP1B plays a regulatory role. The compounds that act as HAP1B inhibitors typically interact with specific domains of the protein, disrupting its association with key intracellular transport machinery.
Chemically, HAP1B inhibitors belong to a diverse group of molecules, each characterized by a specific mechanism of action that prevents the proper binding or function of HAP1B. These inhibitors can exhibit various degrees of specificity and potency, which is influenced by their molecular structure and the nature of their interaction with the protein. Many HAP1B inhibitors share common chemical scaffolds or motifs that allow them to bind to the regulatory domains of HAP1B, while others may inhibit the protein through indirect mechanisms, such as modulating upstream or downstream signaling pathways that regulate HAP1B function. The chemical diversity of these inhibitors allows for a broad range of experimental applications, particularly in the study of intracellular transport, neurobiology, and protein-protein interactions, making them valuable tools in understanding cellular processes associated with HAP1B.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylase, increases the acetylation of histones, potentially leading to the unwinding of chromatin and suppression of HAP1B transcription. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 blocks the ubiquitin-proteasome pathway, which may result in the upregulation of cellular stress proteins that could suppress the transcription machinery involved in HAP1B expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could decrease methylation levels of the HAP1B gene promoter, potentially leading to reduced transcriptional activity of the HAP1B gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could lead to hyperacetylation of histones near the HAP1B gene, potentially resulting in a tightened chromatin structure that decreases the gene's transcriptional efficiency. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is essential for cap-dependent translation initiation; this could result in selective translation inhibition of mRNAs, including those coding for HAP1B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, leading to a blockade of the Akt signaling pathway, which may be necessary for HAP1B expression; this could result in decreased mRNA synthesis for HAP1B. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts endosomal and lysosomal acidification, which can lead to the inhibition of lysosome-dependent degradation pathways that may be involved in the turnover of transcription factors critical for HAP1B gene expression. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1, by inhibiting vacuolar H+-ATPase, may alter intracellular acidification, leading to a disruption of endocytic trafficking pathways that could carry transcriptional regulators for HAP1B. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin irreversibly inhibits PI3K, which may lead to a reduction in the phosphorylation of downstream targets involved in the transcriptional initiation of HAP1B. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein selectively inhibits certain tyrosine kinases, which could lead to a downstream decrease in the signaling required for initiating HAP1B gene transcription. | ||||||